4 ms·
When people die of H1N1, can vaccine companies be sued due to shortage?
Or is the link sufficiently weak that this would not make a strong case?
In particular, many of the families of those who died may have had no intention of getting vaccinated.
And even if they did, the probability of dying from H1N1 is very low anyway.
Finally, many of those families are probably also at fault for not seeking treatment quickly enough after flu symptoms appeared.
- bdfh42 17y agoHow inane. How can getting sick and dying of an airborne flue be someone's fault? For goodness sake - the world is not designed to compensate you for bad fortune - at best it is there to offer you the challenges that make life worth living.
- towndrunk 17y agoExactly!
- cpr 17y agoAre you not aware that the US Government has officially indemnified (made safe from lawsuits) both all federal lawmakers and the H1N1 vaccine suppliers? That's just one of the many suspicious circumstances surrounding the untried vaccines & the program to inoculate everyone. The real question is: Why are we getting vaccines for this flu? It's a lot less deadly than previous seasonal flus. Why the concern?
- amichail 17y agoWhy are we getting vaccines for this flu? It's a lot less deadly than previous seasonal flus. Why the concern? Because it is a highly contagious virus that might mutate into something more deadly.
- deleted 17y ago[deleted]
- evgen 17y ago> The real question is: Why are we getting vaccines for this flu? It's a lot less deadly than previous seasonal flus. Why the concern? Actually, there is no evidence to support the claim that it is less deadly than previous seasonal flus and several bits of research that suggest it might be a bit more deadly than we thought. The first pass of this flu early in the year included some really, really bad reporting out of Mexico that at first made it appear to be the second coming of the 1918 flu and then made it look like a very mild flu strain. So far, what we know is that it spreads very quickly because the general population has very few antibodies that can defend against it. In its current form it is not significantly more deadly than seasonal flu, but its mortality profile is a little different. It is leading to more pneumonia than most seasonal flus and it is also tending to kill more young people than standard seasonal flu, which usually kills the very young and very old but seldom kills people between those two extremes. Given the rate at which flu mutates (and the possibility that this flu could pick up a particularly nasty mutation) and the lack of any significant herd immunity in the general population it is prudent to prepare for the worst and also to get as many people vaccinated as possible.
- dgordon 17y agoApparently, some of the difference in mortality profile is because there hasn't been a major H1N1 flu in quite a while, so older people have some immunity to H1N1 that younger people don't have because their immune systems have never faced such a virus.
- evgen 17y agoFrom what I had read (a New Scientist synopsis of a Univ of Wisconsin study, so my facts may be muddled) it was exposure to the 1918 pandemic that provided H1N1 antibody response. Since that flu variant lasted until 1920 we are talking about people who are at a minimum 89 years old. This is not a large enough cohort to appreciably tilt the mortality profile on its own, there is something else at work here as well.
- lanaer 17y ago“It's a lot less deadly than previous seasonal flus.” Cite? I was under the impression that it was about as dangerous as others.
- catone 17y agoThe real question is: Why are we getting vaccines for this flu? It's a lot less deadly than previous seasonal flus. Why the concern? If that were true (and I'm not sure it is), we have vaccines for the seasonal flu every year...
- wtallis 17y agoThis flu still kills some people. And even for those people who don't suffer serious complications, they are still sick for a few days. If there's no vaccination and the strain becomes epidemic, then you can expect to see at least a 1% drop in GDP solely due to everybody having to miss out on three or four days of work.
- ZachPruckowski 17y agoThe concern isn't that tens of millions of people will die. The concern is that enough of the population could get sick to ground society to a halt. If 10-20% of our hospital staffs and firefighters and police and teachers are sick (or missing work to care for sick relatives), that creates a major strain on the fabric of society. The deadliness of this flu isn't the concern, it's virulence is. And that's ignoring the "it might mutate into something killer" issue.
- dsplittgerber 17y agoThe reason for the indemnification (happened here in Germany as well) is obvious: Without "enough" (a topic for endless discussions) research and trials, the pharma firms don't want to face potentially bankrupting class action law suits in case there is a minor defect with their vaccine - which they could have found if they have had more time to test it. As a business, I would do one of two things: (1) demand indemnification, or (2) raise the price high enough to cover potential damage awards; as the government doesn't want to pay (2), they go for (1).
- jlujan 17y agoIt is an interesting concept but a dangerous one. It cuts at the heart of the conflict between the USPTO, the FDA, NIHS and "big pharma". Drug companies sink mil/billions into developing drugs with the incentive of revenue guarantees from drug patents. However, most big "breakthrough" drugs are heavily funded by the NIHS (other government grants) and therefore... tax payer money. The FDA, instituted to protect the public, is heavily backlogged and drags their feet approving a new drug. Usually, by the time the FDA approves a drug, the patent holder has limited amount of time to make up development costs before the market is flooded with generics. The real question is why any of this exists in the first place? Does the patent system really incentivise the creation of technology? Does the FDA really protect the public? How should this effect drugs that the government and tax payers actually pay (if in part) to develop? With Tamiflu, used to treat H1N1 and other serious flu, there is a company in India that produces a "generic" and could fill the gap in demand. Their generic version has been cleared by the WHO, but due to US patents, cannot be distributed to the US or its trade partners. The same holds true to many "life-saving" drugs, such as HIV/AIDS cocktails. I am not saying that so called "big pharma" is evil or that there is some social justice demanded, I do not think that to be the case, just that the whole system in the US and other countries suffers from serious fundamental issues. To justify suing someone, there must be a claim of wrong doing on account of a specific party. Who is really responsible for the shortage of N1H1 vaccine? I would say we all are...
- maxharris 17y agoYour posts are hurting this community. Please stop using hn as a sounding board for every half-baked random notion that pops into your head. I'm not sure that you really even care about what you're posting. For example: months ago, you asked if it was possible to "stop all mutations in the human genome" (approximately). I wrote a reply in the time that I had, but felt bad that it was incomplete. So a few months later, I spent a few hours detailing particular molecular mechanisms by which mutations are found and removed. I sent it to you via email; you never replied. Now you're posting about H1N1. If I spent time writing something intelligent back, I don't think it would matter. Maybe you are not doing it intentionally, but what you are doing is indistinguishable from trolling.
- amichail 17y agoYour email reply is certainly worth a post here. Why don't you post it? Or if you like, I could post it indicating that it was your reply?